Brought to you by:
Multidisciplinary approach to diabetic foot ulcers in rural America leads to NIH grant
Samantha Minc, MD, MPH, associate professor of surgery at Duke University, has been awarded a National Institutes of Health (NIH) R03 grant to support her research project, “Understanding diabetes and peripheral arterial disease [PAD]-related amputation in North Carolina.” The R03…
Redefining ‘optimal medical therapy’ for vascular patients
Vascular and endovascular surgeons are frequently the only specialists other than primary care involved in the longitudinal care of their patients afflicted with clinically active vascular disease. As such, while scrutinizing the longitudinal and periprocedural outcomes in their patients, involvement…
ACC.25: Semaglutide improves walk distance for PAD patients with diabetes
Semaglutide significantly improved maximal walking distance in people with symptomatic peripheral arterial disease (PAD) and type 2 diabetes in a trial designed to evaluate the use of a GLP-1 agonist to manage PAD. In addition to improvements in walking ability…
BEST-CLI: Trial results endure in analysis of patients who presented with diabetes
Diabetes affects approximately 70% of patients with chronic limb-threatening ischemia (CLTI) and is associated with more severe presentation, driven mostly by higher rates of wounds and infections, according to a recently presented retrospective analysis of BEST-CLI randomized controlled trial data.…
Overcoming barriers and finding solutions for diabetes-related amputations among underserved populations
Diabetes-related lower extremity amputations (LEA) disproportionately impact racial minorities and low-income groups. The Vascular Volunteers in Service to All (VISTA) assessment tool identified significant barriers to effective care from a patient’s perspective, including financial constraints, systemic issues, time and access…
Could metformin be first-ever medical treatment that is effective at managing aneurysm disease?
There is a global interest in assessing whether metformin, which has a long track record of safety and efficacy, is relatively inexpensive and is taken by millions of people every day for type-2 diabetes, has an effect on the progression…
For Diabetes Month, diabetes resources for SVS members, patients
November is National Diabetes Month. Because SVS members treat patients with the condition—and its complications—the Society has numerous educational resources available. “Diabetes and Vascular Disease” is one of nearly 10 patient education fliers produced by the SVS Foundation as part…
A vascular mission: Defying assumptions in the fight against amputation in disadvantaged areas
Lyssa Ochoa, MD, is used to the assumptions. One: ”What a nice program you have.” Another: “It must be so nice that you can give away all of this charity care.” Ochoa is the founding vascular surgeon behind the SAVE…
SVS member named 2023 Presidential Leadership Scholar
Society for Vascular Surgery (SVS) member Anahita Dua, MD, has been named a Presidential Leadership Scholar for 2023. She is one of 60 scholars in this eighth annual class. Dua is an associate professor of surgery at Massachusetts General Hospital…
SAVS 2023: Study points toward CKD patients who would most benefit from renal artery stenting
A new study probing which chronic kidney disease (CKD) patients would benefit most from renal artery stenting points toward those who experience a more rapid decline in renal function over six months prior to the procedure. It is an area…